{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:03:24Z","timestamp":1784347404343,"version":"3.55.0"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7179-26","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:10:43Z","timestamp":1784326243000},"source":"Crossref","is-referenced-by-count":0,"title":["MRI-negative combined central and peripheral demyelination involving a spinal cord with anti-lactosylceramide antibody"],"prefix":"10.2169","author":[{"given":"Tetsuhiro","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Neurology, Kyoto Yamashiro General Medical Center, Japan"},{"name":"Department of Neurology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maika","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Yamashiro General Medical Center, Japan"},{"name":"Department of Neurology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Yamashiro General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Mutoh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Yamashiro General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ogata H, Matsuse D, Yamasaki R, et al. A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry 87 (1): 29-36, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cortese A, Franciotta D, Alfonsi E, et al. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment. J Neurol Sci 363: 182-187, 2016.","DOI":"10.1016\/j.jns.2016.02.022"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Andrusi\u00f3w S, Dziadkowiak E, Koszewicz M. Clinical and electrophysiological features of adult patients with combined central and peripheral demyelination- a systematic review. Front Immunol 16: 1572507, 2025. Published 2025 Jun 4.","DOI":"10.3389\/fimmu.2025.1572507"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saito K, Toru S, Shima S, Mutoh T. Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype. Clin Neurol Neurosurg 172: 90-92, 2018.","DOI":"10.1016\/j.clineuro.2018.06.046"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takegami N, Sakuishi K, Yamaguchi-Takegami N, et al. Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases. J Neuroimmunol 378: 578086, 2023.","DOI":"10.1016\/j.jneuroim.2023.578086"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takewaki D, Lin Y, Sato W, et al. Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis. Neurol Neuroimmunol Neuroinflamm 5 (3): e456, 2018. Published 2018 Apr 2.","DOI":"10.1212\/NXI.0000000000000456"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sechi E, Krecke KN, Pittock SJ, et al. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler 27 (2): 303-308, 2021.","DOI":"10.1177\/1352458520907900"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Mutoh T, Ueda A, Niimi Y. Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti-neutral glycolipid antibody. FEBS Open Bio 13 (9): 1580-1586, 2023.","DOI":"10.1002\/2211-5463.13578"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miura T, Sonoo M, Shimizu T. Establishment of standard values for the latency, interval and amplitude parameters of tibial nerve somatosensory evoked potentials (SEPs). Clin Neurophysiol 114 (7): 1367-1378, 2003.","DOI":"10.1016\/S1388-2457(03)00094-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision [published correction appears in <i>Eur J Neurol<\/i>. 2022 Apr;29 (4):1288.]. Eur J Neurol 28 (11): 3556-3583, 2021.","DOI":"10.1111\/ene.14959"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Shima S, Kawamura N, Ishikawa T, et al. Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy. Neurology 82 (2): 114-118, 2014.","DOI":"10.1212\/WNL.0000000000000015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rinaldi S, Davies A, Fehmi J, et al. Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders. Neurol Neuroimmunol Neuroinflamm 8 (1): e924, 2020Published 2020 Dec 3.","DOI":"10.1212\/NXI.0000000000000924"},{"key":"13","unstructured":"13. Fujioka H, Takahashi H, Ishii K, et al. Magnetic resonance imaging-negative encephalomyeloradiculopathy diagnosed by anti-lactosylceramide antibody positivity and electrophysiological findings: a case report and review of the literature. Intern Med. Published online August 7, 2025."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7179-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:25:42Z","timestamp":1784345142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7179-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":13,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7179-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7179-26"}}